Gray-market BPC-157 users report months of neurological symptoms
Futurism amplifies KFF Health News reporting on buyers of research-labeled peptides who say side effects began within days of first use.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 14 16:00 ETSource: Futurism
The wire
- 01A weightlifter who bought BPC-157 from a research-chemical supplier and used it nasally for three days reported fatigue, anxiety, and eye and muscle spasms lasting months; a second user combining BPC-157 with TB-4 described facial numbness and two months of migraines.
- 02Clinicians and pharmacists fielding questions about research-labeled peptides now have named self-reported harm cases to cite alongside the absence of controlled human data.
- 03These are self-reported accounts, not clinical workups, and product contents were not independently verified; former FDA official Peter Lurie says clinical benefit in humans remains unshown.
From the source
Read at futurism.comPeople Taking Gray Market Peptides Say They’re Causing Bizarre Medical Issues
With gray market medical snake oil flooding the market and the head of the Food and Drug Administration smoking DMT behind the wheel , peptides are quickly becoming the go-to hack for just about any malady you can imagine. Yet for as popular as they are, they’re not necessarily safe to use — a fact many new users are starting to discover the hard way.
